WaferGen Reports Spike in Q1 Revenues from SmartChip Early-Access Sales | GenomeWeb

This article was originally published on May 17.

WaferGen Biosystems today reported a rise in first-quarter revenues driven by sales related to its SmartChip real-time PCR system, currently being evaluated by early-access customers.

WaferGen also disclosed last week an accounting error in its full-year and fourth-quarter 2009 that caused the company to underreport its yearly net loss and overreport its accumulated year-end deficit.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.